SARS–CoV‐2 infection and COVID‐19 outcomes in rheumatic diseases: a systematic literature review and meta‐analysis

R Conway, AA Grimshaw, MF Konig… - Arthritis & …, 2022 - Wiley Online Library
Objective The relative risk of SARS–CoV‐2 infection and COVID‐19 disease severity among
people with rheumatic and musculoskeletal diseases (RMDs) compared to those without …

Epidemiology of systemic lupus erythematosus

GJ Pons-Estel, MF Ugarte-Gil… - Expert review of clinical …, 2017 - Taylor & Francis
Introduction: Systemic lupus erythematosus (SLE) is a disease distributed worldwide, which
occurs in both genders, and across racial/ethnic and age groups; however, higher rates are …

Swinging the pendulum: lessons learned from public discourse concerning hydroxychloroquine and COVID-19

SE Sattui, JW Liew, ER Graef… - Expert Review of …, 2020 - Taylor & Francis
Introduction Several months into the COVID-19 pandemic, safe and effective treatments
against this global health disaster have yet to be identified. Clinical research trials around …

[HTML][HTML] Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: results from the COVID-19 Global …

JA Sparks, ZS Wallace, AM Seet… - Annals of the …, 2021 - ard.bmj.com
Objective To investigate baseline use of biologic or targeted synthetic (b/ts) disease-
modifying antirheumatic drugs (DMARDs) and COVID-19 outcomes in rheumatoid arthritis …

A rush to judgment? Rapid reporting and dissemination of results and its consequences regarding the use of hydroxychloroquine for COVID-19

AHJ Kim, JA Sparks, JW Liew, MS Putman… - Annals of internal …, 2020 - acpjournals.org
Hydroxychloroquine, an essential treatment for many patients with rheumatologic conditions,
has garnered widespread attention as a potential treatment for COVID-19 infection. The …

First Latin American clinical practice guidelines for the treatment of systemic lupus erythematosus: Latin American Group for the Study of Lupus (GLADEL, Grupo …

BA Pons-Estel, E Bonfa, ER Soriano… - Annals of the …, 2018 - ard.bmj.com
Systemic lupus erythematosus (SLE), a complex and heterogeneous autoimmune disease,
represents a significant challenge for both diagnosis and treatment. Patients with SLE in …

Vaccination against COVID-19: expectations and concerns of patients with autoimmune and rheumatic diseases

R Felten, M Dubois, MF Ugarte-Gil… - The Lancet …, 2021 - thelancet.com
Vaccination is an important and effective tool to prevent infections in the general population,
as well as in patients with autoimmune and inflammatory rheumatic diseases. It has been …

Tolerance of COVID-19 vaccination in patients with systemic lupus erythematosus: the international VACOLUP study

R Felten, L Kawka, M Dubois, MF Ugarte-Gil… - The Lancet …, 2021 - thelancet.com
Comment e614 www. thelancet. com/rheumatology Vol 3 September 2021 is that side-
effects after COVID-19 vaccination in patients with SLE are common (around 50%) but do …

The number of flares patients experience impacts on damage accrual in systemic lupus erythematosus: data from a multiethnic Latin American cohort

MF Ugarte-Gil, E Acevedo-Vásquez… - Annals of the …, 2015 - ard.bmj.com
Purpose To determine the association between the number of flares systemic lupus
erythematosus (SLE) patients experience and damage accrual, independently of other …

COVID-19 vaccine perceptions and uptake: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey

M Putman, K Kennedy, E Sirotich, JW Liew… - The Lancet …, 2022 - thelancet.com
Before widespread vaccination programmes, potential side-effects and flares after COVID-
19 vaccination were frequent reasons for vaccine hesitancy among people with rheumatic …